Ligand Pharmaceuticals Incorporated (LGND) — Financial Flexibility Index
Ligand Pharmaceuticals Incorporated (LGND) has a Financial Flexibility Index of 0.09x as of March 2026. Free cash flow of $48.92 Million (operating CF $48.69 Million minus capex $228.00K) represents 0% of total liabilities ($534.78 Million). Also explore Ligand Pharmaceuticals Incorporated net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Ligand Pharmaceuticals Incorporated Financial Flexibility Index (1994–2025)
Historical Financial Flexibility Index trend for Ligand Pharmaceuticals Incorporated across 32 annual periods. Check LGND strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Ligand Pharmaceuticals Incorporated (1994–2025)
Year-by-year free cash flow to debt coverage for Ligand Pharmaceuticals Incorporated. For the full company profile including market capitalisation, see market value of Ligand Pharmaceuticals Incorporated.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.09x | $49.81 Million | $49.36 Million | $543.42 Million | ▼ -91.3% |
| 2024 | 1.05x | $116.69 Million | $97.05 Million | $111.33 Million | ▼ -12.5% |
| 2023 | 1.20x | $103.43 Million | $49.58 Million | $86.30 Million | ▲ +27.1% |
| 2022 | 0.94x | $155.77 Million | $137.85 Million | $165.18 Million | ▲ +413.1% |
| 2021 | 0.18x | $87.56 Million | $78.80 Million | $476.43 Million | ▲ +103.2% |
| 2020 | 0.09x | $59.04 Million | $54.59 Million | $652.76 Million | ▲ +345.8% |
| 2019 | -0.04x | $-26.78 Million | $-29.34 Million | $727.68 Million | ▼ -112.5% |
| 2018 | 0.29x | $205.95 Million | $194.06 Million | $699.89 Million | ▼ -26.3% |
| 2017 | 0.40x | $100.72 Million | $93.57 Million | $252.37 Million | ▲ +0.8% |
| 2016 | 0.40x | $91.32 Million | $63.00 Million | $230.73 Million | ▲ +72.8% |
| 2015 | 0.23x | $52.59 Million | $41.73 Million | $229.54 Million | ▲ +113.5% |
| 2014 | 0.11x | $25.07 Million | $20.57 Million | $233.62 Million | ▼ -76.9% |
| 2013 | 0.47x | $25.63 Million | $20.69 Million | $55.10 Million | ▲ +310.8% |
| 2012 | 0.11x | $8.80 Million | $161.00K | $77.78 Million | ▲ +1276.7% |
| 2011 | -0.01x | $-1.09 Million | $-1.17 Million | $113.70 Million | ▲ +97.1% |
| 2010 | -0.33x | $-27.00 Million | $-27.07 Million | $82.55 Million | ▼ -8.1% |
| 2009 | -0.30x | $-33.28 Million | $-33.80 Million | $109.95 Million | ▼ -173.4% |
| 2008 | -0.11x | $-20.13 Million | $-20.62 Million | $181.81 Million | ▲ +83.6% |
| 2007 | -0.67x | $-97.29 Million | $-97.73 Million | $144.16 Million | ▼ -47.4% |
| 2006 | -0.46x | $-136.74 Million | $-138.52 Million | $298.70 Million | ▼ -542.6% |
| 2005 | 0.10x | $43.96 Million | $8.37 Million | $425.04 Million | ▲ +350.7% |
| 2004 | 0.02x | $9.36 Million | $5.75 Million | $407.78 Million | ▲ +73.1% |
| 2003 | 0.01x | $3.06 Million | $274.00K | $230.53 Million | ▲ +111.9% |
| 2002 | -0.11x | $-21.95 Million | $-25.11 Million | $196.59 Million | ▼ -9.2% |
| 2001 | -0.10x | $-17.93 Million | $-19.91 Million | $175.35 Million | ▲ +62.7% |
| 2000 | -0.27x | $-46.27 Million | $-47.35 Million | $168.55 Million | ▼ -109.4% |
| 1999 | -0.13x | $-21.00 Million | $-60.50 Million | $160.20 Million | ▲ +65.8% |
| 1998 | -0.38x | $-64.20 Million | $-66.60 Million | $167.40 Million | ▼ -208.1% |
| 1997 | -0.12x | $-9.10 Million | $-13.40 Million | $73.10 Million | ▲ +74.4% |
| 1996 | -0.49x | $-32.90 Million | $-33.30 Million | $67.60 Million | ▲ +15.4% |
| 1995 | -0.58x | $-37.70 Million | $-37.90 Million | $65.50 Million | ▲ +14.3% |
| 1994 | -0.67x | $-13.70 Million | $-14.30 Million | $20.40 Million | — |